Regular medication as a risk factor for intracranial aneurysms: A comparative case–control study

R Jabbarli, M Darkwah Oppong… - European Stroke …, 2023 - journals.sagepub.com
Background: Previous medical history strongly contributes to the genesis of intracranial
aneurysms (IA). A possible impact of regular medication on the occurrence of abdominal …

Use of antihypertensive medication and formation of de novo intracranial aneurysms

S Räisänen, J Huttunen, TJ Huuskonen… - European Journal of …, 2022 - Wiley Online Library
Background and purpose Hypertension is a risk factor for subarachnoid hemorrhage and is
also considered a risk factor for saccular intracranial aneurysm (sIA) formation. However …

[引用][C] Reevaluating the impact of antihypertensive medication on intracranial aneurysm formation: a call for clarification and further study

Z Yin, A Wang, J Zhao - European Journal of Neurology, 2024 - Wiley Online Library
Recently, we read with great interest the article 'Use of antihypertensive medication and
formation of de novo intracranial aneurysms' by Räisänen et al.[1]. The study found that …

Candidate drugs for preventive treatment of unruptured intracranial aneurysms: A cross-sectional study

K Shimizu, H Imamura, S Tani, H Adachi, C Sakai… - PloS one, 2021 - journals.plos.org
Background and purpose Establishment of drug therapy to prevent rupture of unruptured
intracranial aneurysms (IAs) is needed. Previous human and animal studies have gradually …

Patients taking antithrombotic medications present less frequently with ruptured aneurysms

PL Nisson, T Meybodi, TW Secomb, GK Berger… - World Neurosurgery, 2020 - Elsevier
Background Conflicting findings exist on the protective role of aspirin against aneurysmal
subarachnoid hemorrhage (SAH). In this retrospective analysis, we compare the risk of SAH …

Independent risk factors for intracranial aneurysms and their joint effect: a case-control study

MHM Vlak, GJE Rinkel, P Greebe, A Algra - Stroke, 2013 - Am Heart Assoc
Background and Purpose—Three percent of the population has an unruptured intracranial
aneurysm (UIA). We aimed to identify independent risk factors from lifestyle and medical …

“Sit back, observe, and wait.” Or is there a pharmacologic preventive treatment for cerebral aneurysms?

MM Valença - Neurosurgical review, 2013 - Springer
Intracranial aneurysms (IA) are a relatively frequent vascular abnormality. The prevailing
opinion is that cerebral aneurysmal disease is related to hemodynamic and genetic factors …

Response to letter regarding article,“lifelong rupture risk of intracranial aneurysms depends on risk factors: a prospective finnish cohort study”

M Korja, H Lehto, S Juvela - Stroke, 2014 - Am Heart Assoc
We thank Drs Kirchoff-Torres and Labovitz for their interest in our article. 1 The authors fear
that the presented results may be overgeneralized. We share the view that the applicability …

Unruptured intracranial aneurysms: contemporary data and management

KAM Hackenberg, D Hänggi, N Etminan - Stroke, 2018 - Am Heart Assoc
Patient-related, modifiable risk factors—in addition to arterial hypertension, established in
PHASES—are current cigarette smoking and heavy alcohol consumption. 14, 15 For …

Atorvastatin and growth, rupture of small unruptured intracranial aneurysm: results of a prospective cohort study

J Wang, J Weng, H Li, Y Jiao, W Fu… - Therapeutic …, 2021 - journals.sagepub.com
Background and aims: The role of statins in unruptured intracranial aneurysm (UIA) growth
and rupture remains ambiguous. This study sought to determine whether atorvastatin is …